<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:chebi fb="105" ids="17234">glucose</z:chebi> toxicity leads to beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> with decreased beta cell mass as a consequence </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="15033">Thioredoxin</z:chebi>-interacting protein (TXNIP) is a critical mediator of <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Since <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> leads to elevated serum insulin, we hypothesised that insulin is involved in the regulation of TXNIP protein levels in beta cells </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We studied the production of TXNIP in INS-1E beta cells and in islets of Psammomys obesus, an animal model of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, in response to <z:chebi fb="105" ids="17234">glucose</z:chebi> and different modulators of insulin secretion </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: TXNIP production was markedly augmented in islets from diabetic P. obesus and in beta cells exposed to high <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, adding insulin to the culture medium or stimulating insulin secretion with different secretagogues suppressed TXNIP </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibition of <z:chebi fb="105" ids="17234">glucose</z:chebi> and fatty acid-stimulated insulin secretion with <z:chebi fb="0" ids="4495">diazoxide</z:chebi> increased TXNIP production in beta cells </plain></SENT>
<SENT sid="7" pm="."><plain>Nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO), a repressor of TXNIP, enhanced insulin signal transduction, whereas inhibition of NO synthase abolished its activation, suggesting that TXNIP inhibition by NO is mediated by stimulation of insulin signalling </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment of beta cells chronically exposed to high <z:chebi fb="105" ids="17234">glucose</z:chebi> with insulin reduced beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Txnip knockdown mimicking the effect of insulin prevented <z:chebi fb="105" ids="17234">glucose</z:chebi>-induced beta cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Insulin is a potent repressor of TXNIP, operating a negative feedback loop that restrains the stimulation of TXNIP by <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Repression of TXNIP by insulin is probably an important compensatory mechanism protecting beta cells from oxidative damage and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>